Blueprint Medicines Corporation
BPMC
|
$86.87
-2.28%
-2.34%
800K
|
Health Technology
(0.0% 1d) (-0.4% 1m) (82.5% 1y) (0.0% 2d) (0.0% 3d) (3.2% 7d) (Infinity% volume)
Earnings Calendar: 2023-10-26
Market Cap: $ 5,316,444,000
http://www.blueprintmedicines.com
Sec Filling | Patents | 383 employees
(US) Blueprint Medicines Corp. is a precision therapy company. It focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases and cancer immunotherapy. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.
cancer genomic immunotherapy
Drugs
Ayvakit (avapritinib)GAVRETO (pralsetinib)
add to watch list Paper trade email alert is off
Press-releases
Blueprint Medicines to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
BPMC | $86.87 -2.28% -2.34% 800K
|
Health Technology
|
| O: 2.12%
H: 0.0%
C: 0.0%
first report financial results
Blueprint Medicines to Host Webcast and Conference Call Highlighting Emerging Opportunities for Mast Cell-Targeted Therapeutics
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
BPMC | $86.87 -2.28% -2.34% 800K
|
Health Technology
|
| O: 1.08%
H: 1.19%
C: 0.85%
conference for therapeutics
Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-04 (Crawled : 20:00) - prnewswire.com
BPMC | $86.87 -2.28% -2.34% 800K
|
Health Technology
|
| O: -0.75%
H: 1.96%
C: 1.83%
nasdaq grants
Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-06 (Crawled : 21:00) - prnewswire.com
BPMC | $86.87 -2.28% -2.34% 800K
|
Health Technology
|
| O: -0.01%
H: 2.63%
C: 1.85%
nasdaq grants
Aerovate Therapeutics Board of Directors Appoints Habib Dable as Board Chair
Published: 2024-03-06 (Crawled : 13:00) - globenewswire.com
PEPG | $10.59 -10.6% -11.85% 120K
|
|
| O: -2.65%
H: 4.17%
C: -4.82%
AVTE M | $21.86 1.2% 1.19% 220K
|
Professional, Scientific, and T...
|
| O: -2.08%
H: 7.76%
C: 6.73%
BPMC | $86.87 -2.28% -2.34% 800K
|
Health Technology
|
| O: -0.75%
H: 3.12%
C: 1.55%
therapeutics
Blueprint Medicines Highlights AYVAKIT® (avapritinib) Long-Term Efficacy and Safety Data and Advances in Mast Cell Disease Research at 2024 AAAAI Annual Meeting
Published: 2024-02-23 (Crawled : 13:00) - prnewswire.com
BPMC | $86.87 -2.28% -2.34% 800K
|
Health Technology
|
| O: 0.8%
H: 5.19%
C: 3.23%
ayvakit disease cell research meeting
Blueprint Medicines Reports Fourth Quarter and Full Year 2023 Results
Published: 2024-02-15 (Crawled : 13:00) - biospace.com/
BPMC | $86.87 -2.28% -2.34% 800K
|
Health Technology
|
| O: 1.0%
H: 15.06%
C: 12.89%
year results
Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-02-05 (Crawled : 21:00) - prnewswire.com
BPMC | $86.87 -2.28% -2.34% 800K
|
Health Technology
|
| O: -0.33%
H: 1.53%
C: 0.99%
nasdaq grants
Blueprint Medicines to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024
Published: 2024-02-01 (Crawled : 13:00) - prnewswire.com
BPMC | $86.87 -2.28% -2.34% 800K
|
Health Technology
|
| O: -0.25%
H: 1.98%
C: 0.69%
report year financial results
Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-01-05 (Crawled : 21:00) - prnewswire.com
BPMC | $86.87 -2.28% -2.34% 800K
|
Health Technology
| Email alert
Add to watchlist
nasdaq grants
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10